ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Who we are
We are currently looking for a Health and Safety Consultant to join our small team at Health & Safety Works.
Our team is based in East Anglia, and all consultants work from home. You may however need to travel further afield.
About the role
Are you a machine learning researcher with expertise in deep generative modelling, eager to apply your methods to some of the most pressing challenges in global health? We are looking for a Research Associate to lead methodological development at the interface of deep learning and infectious disease modelling, working within a highly collaborative international team at Imperial College London.
What you would be doing
*Guest blog by Professor Alan M. Palmer, Chief Executive Officer, Elixa MediScience.

If you would like to submit a guest blog please email [email protected].
The industry promised AI would transform medicine. Instead, it delivered a speed boost nobody needed and a clinical failure rate nobody fixed.
The Research Team at Alzheimer’s Research UK (ARUK) is dedicated to funding ground breaking research to understand, diagnose, and cure dementia diseases. ARUK funds dementia research through an extensive portfolio of grant schemes and strategic initiatives both nationally and internationally.
*Guest blog by Pivotal. For more information on the information in this blog post please contact Natalia Farr - [email protected].
If you would like to submit a guest blog please email [email protected].
About the Opportunity
Deep Science Ventures (DSV), a UK-based deeptech venture creator, and Medicines Discovery Catapult (MDC), a life sciences service dedicated to turning drug discovery into commercial breakthroughs, today announced a strategic collaboration to address challenges in delivering medicines into the brain.
Oxford, UK – 3 June 2026 – PrecisionLife, a leader in AI-driven precision medicine for chronic diseases, today announced the appointments of Dr Pradip Banerjee, PhD, MBA, as an Independent Non-Executive Director and Dr Kam Pooni, PhD, as Chief Product Officer.